Details for New Drug Application (NDA): 018074

NDA 018074 describes PHENDIMETRAZINE TARTRATE, which is a drug marketed by Graham Dm, Virtus, Sandoz, Vitarine, Barr, Chartwell, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Nexgen Pharma Inc, Nostrum Labs Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs, and is included in sixty-five NDAs. It is available from twelve suppliers. Additional details are available on the PHENDIMETRAZINE TARTRATE profile page.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

Summary for 018074

Tradename:	PHENDIMETRAZINE TARTRATE
Applicant:	Virtus
Ingredient:	phendimetrazine tartrate
Patents:	0

Pharmacology for NDA: 018074

Physiological Effect

Appetite Suppression Increased Sympathetic Activity

Suppliers and Packaging for NDA: 018074

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	018074	NDA	A-S Medication Solutions	50090-3988	50090-3988-0	14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-3988-0)
PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	CAPSULE, EXTENDED RELEASE;ORAL	018074	NDA	A-S Medication Solutions	50090-3988	50090-3988-1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (50090-3988-1)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE, EXTENDED RELEASE;ORAL			Strength	105MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Complete Access Available with Subscription